Butyrate Inhibits Interleukin-1-Mediated Nuclear Factor-Kappa B Activation in Human Epithelial Cells
Authors:
- 1 September 2001
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 46 (9) , 1968-1973
Abstract
Nuclear factor-kappa B (NF-κB) is a critical transcription factor for the inducible expression of multiple genes involved in inflammation. NF-κB is sequestered in the cytoplasm by inhibitory IκB...Keywords
This publication has 31 references indexed in Scilit:
- Protein kinase C–dependent activation of NF-κB in enterocytes is independent of IκB degradationGastroenterology, 1999
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Short‐chain fatty acid topical treatment in distal ulcerative colitisAlimentary Pharmacology & Therapeutics, 1995
- Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritisArthritis & Rheumatism, 1995
- Topical treatment of refractory distal ulcerative colitis with 5-ASA and sodium butyrateDigestive Diseases and Sciences, 1995
- Structure, Regulation and Function of NF-kappaBAnnual Review of Cell Biology, 1994
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994
- Short-chain fatty acid enemasDiseases of the Colon & Rectum, 1992
- Rectal irrigation with short-chain fatty acids for distal ulcerative colitisDigestive Diseases and Sciences, 1991
- Treatment of Diversion Colitis with Short-Chain-Fatty Acid IrrigationNew England Journal of Medicine, 1989